{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:56:45Z","timestamp":1793451405234,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the era of potent P2Y<jats:sub>12<\/jats:sub> inhibitors, according to current guidelines, treatment with glycoprotein IIb\/IIIa inhibitors (GPIs) should be limited to bail-out and\/or highly thrombotic situations. Similarly, the recommendation for aspiration thrombectomy (AT) is downgraded to very selective use. We examine the prevalence, and predictors of GPI and AT use in STEMI patients referred to primary percutaneous coronary intervention (PCI). Data on 116,873 consecutive STEMI patients referred to primary PCI in Poland between 2015 and 2020 were analyzed. GPIs were administered in 29.3%, AT was used in 11.6%, and combined treatment with both in 6.1%. There was a mild trend toward a decrease in GPI and AT usage during the analyzed years. On the contrary, there was a rapid growth of the ticagrelor\/prasugrel usage rate from 6.5 to 48.1%. Occluded infarct-related artery at baseline and no-reflow during PCI were the strongest predictors of GPI administration (OR 2.3; 95% CI 2.22\u20132.38 and OR 3.47; 95% CI 3.13\u20133.84, respectively) and combined usage of GPI and AT (OR 4.4; 95% CI 4.08\u20134.8 and OR 3.49; 95% CI 3.08\u20133.95 respectively) in a multivariate logistic regression model. Similarly, the administration of ticagrelor\/prasugrel was an independent predictor of both adjunctive treatment strategies. In STEMI patients in Poland, GPIs are selectively used in one in four patients during primary PCI, and the combined usage of GPI and AT is marginal. Despite the rapid growth in potent P2Y<jats:sub>12<\/jats:sub> inhibitors usage in recent years, GPIs are selectively used at a stable rate during PCI in highly thrombotic lesions.<\/jats:p>","DOI":"10.1007\/s11239-023-02811-z","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T09:03:03Z","timestamp":1682326983000},"page":"156-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thrombus containing lesions strategies during primary percutaneous coronary interventions in ST-segment elevation myocardial infarction: insights from ORPKI National Registry"],"prefix":"10.1007","volume":"56","author":[{"given":"Tomasz","family":"Rakowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"W\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof P.","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Siudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zasada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zdzierak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Tokarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Rzeszutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"Bartu\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Surdacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-5076","authenticated-orcid":false,"given":"Artur","family":"Dziewierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"2811_CR1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","volume":"293","author":"G De Luca","year":"2005","unstructured":"De Luca G, Suryapranata H, Stone GW et al (2005) Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293:1759\u20131765","journal-title":"JAMA"},{"issue":"17","key":"2811_CR2","doi-asserted-by":"publisher","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","volume":"17","author":"DJ Angiolillo","year":"2022","unstructured":"Angiolillo DJ, Galli M, Collet JP, Kastrati A, O\u2019Donoghue ML (2022) Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention 17(17):e1371\u2013e1396","journal-title":"EuroIntervention"},{"key":"2811_CR3","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, TRITON-TIMI 38 Investigators et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"2811_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"2811_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, ESC Scientific Document Group et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119\u2013177","journal-title":"Eur Heart J"},{"issue":"6","key":"2811_CR6","first-page":"697","volume":"70","author":"M Galli","year":"2022","unstructured":"Galli M, Migliaro S, Rodolico D et al (2022) Intracoronary bolus of glycoprotein IIb\/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarction. Minerva Cardiol Angiol 70(6):697\u2013705","journal-title":"Minerva Cardiol Angiol"},{"key":"2811_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/CIRCINTERVENTIONS.112.972323","volume":"5","author":"D Alexopoulos","year":"2012","unstructured":"Alexopoulos D, Xanthopoulou I, Gkizas V et al (2012) Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 5:797\u2013804","journal-title":"Circ Cardiovasc Interv"},{"key":"2811_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.resuscitation.2014.02.004","volume":"85","author":"K Ibrahim","year":"2014","unstructured":"Ibrahim K, Christoph M, Schmeinck S et al (2014) High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation 85:649\u2013656","journal-title":"Resuscitation"},{"key":"2811_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11239-017-1579-9","volume":"45","author":"T Rakowski","year":"2018","unstructured":"Rakowski T, Siudak Z, Dziewierz A, Plens K, Kleczy\u0144ski P, Dudek D (2018) Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry. J Thromb Thrombolysis 45:151\u2013157","journal-title":"J Thromb Thrombolysis"},{"key":"2811_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11239-018-1794-z","volume":"47","author":"T Rakowski","year":"2019","unstructured":"Rakowski T, De Luca G, Siudak Z et al (2019) Characteristics of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Poland: data from the ORPKI national registry. J Thromb Thrombolysis 47:462\u2013466","journal-title":"J Thromb Thrombolysis"},{"key":"2811_CR11","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.amjcard.2019.07.021","volume":"124","author":"T Rakowski","year":"2019","unstructured":"Rakowski T, W\u0119giel M, Siudak Z et al (2019) Prevalence and predictors of coronary artery perforation during percutaneous coronary interventions (from the ORPKI National Registry in Poland). Am J Cardiol 124:1186\u20131189","journal-title":"Am J Cardiol"},{"key":"2811_CR12","first-page":"340","volume":"17","author":"M Lesiak","year":"2021","unstructured":"Lesiak M, Komosa A (2021) Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes. Postepy Kardiol Interwencyjnej 17:340\u2013343","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"2811_CR13","first-page":"141","volume":"17","author":"S Tubek","year":"2021","unstructured":"Tubek S, Kuliczkowski W, G\u0105sior M et al (2021) Antiplatelets in acute coronary syndrome in Poland - from guidelines to clinical practice. Postepy Kardiol Interwencyjnej 17:141\u2013154","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"2811_CR14","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/eurheartj\/ehq143","volume":"31","author":"K Huber","year":"2010","unstructured":"Huber K, Holmes DR Jr, van Hof AW et al (2010) Use of glycoprotein IIb\/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. Eur Heart J 31:1708\u20131716","journal-title":"Eur Heart J"},{"key":"2811_CR15","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","volume":"344","author":"G Montalescot","year":"2001","unstructured":"Montalescot G, Barragan P, Wittenberg O, ADMIRAL Investigators et al (2001) Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term follow-up platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344:1895\u20131903","journal-title":"N Engl J Med"},{"key":"2811_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/clc.23654","volume":"44","author":"K Blanchart","year":"2021","unstructured":"Blanchart K, Heudel T, Ardouin P et al (2021) Glycoprotein IIb\/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre-treated with newer P2Y12 inhibitors. Clin Cardiol 44:1080\u20131088","journal-title":"Clin Cardiol"},{"issue":"9","key":"2811_CR17","doi-asserted-by":"publisher","first-page":"e007241","DOI":"10.1161\/CIRCINTERVENTIONS.118.007241","volume":"11","author":"N Danchin","year":"2018","unstructured":"Danchin N, Puymirat E, Cayla G, FAST-MI Investigators et al (2018) One-year survival after ST-segment-elevation myocardial infarction in relation with prehospital administration of dual antiplatelet therapy. Circ Cardiovasc Interv 11(9):e007241","journal-title":"Circ Cardiovasc Interv"},{"key":"2811_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/09537104.2016.1218453","volume":"28","author":"V Roule","year":"2017","unstructured":"Roule V, Agueznai M, Sabatier R et al (2017) Safety and efficacy of IIb\/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: a meta-analysis of pivotal trials. Platelets 28:174\u2013181","journal-title":"Platelets"},{"key":"2811_CR19","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1161\/CIRCULATIONAHA.107.742312","volume":"117","author":"R Jaffe","year":"2008","unstructured":"Jaffe R, Charron T, Puley G, Dick A, Strauss BH (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117:3152\u20133156","journal-title":"Circulation"},{"key":"2811_CR20","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1093\/eurheartj\/ehn421","volume":"24","author":"AA Bavry","year":"2008","unstructured":"Bavry AA, Kumbhani DJ, Bhatt DL (2008) Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J 24:2989\u20133001","journal-title":"Eur Heart J"},{"key":"2811_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ahj.2010.07.024","volume":"160","author":"D Dudek","year":"2010","unstructured":"Dudek D, Mielecki W, Burzotta F et al (2010) Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial). Am Heart J 160:966\u2013972","journal-title":"Am Heart J"},{"key":"2811_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2008.10.017","volume":"53","author":"G Sardella","year":"2009","unstructured":"Sardella G, Mancone M, Bucciarelli-Ducci C et al (2009) Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol 53:309\u2013315","journal-title":"J Am Coll Cardiol"},{"key":"2811_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa0706416","volume":"358","author":"T Svilaas","year":"2008","unstructured":"Svilaas T, Vlaar PJ, van der Horst IC et al (2008) Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358:557\u2013567","journal-title":"N Engl J Med"},{"key":"2811_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1405707","volume":"371","author":"B Lagerqvist","year":"2014","unstructured":"Lagerqvist B, Fr\u00f6bert O, Olivecrona GK et al (2014) Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med 371:1111\u20131120","journal-title":"N Engl J Med"},{"key":"2811_CR25","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","volume":"369","author":"O Fr\u00f6bert","year":"2013","unstructured":"Fr\u00f6bert O, Lagerqvist B, Olivecrona GK, TASTE Trial et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369:1587\u20131597","journal-title":"N Engl J Med"},{"key":"2811_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","volume":"372","author":"SS Jolly","year":"2015","unstructured":"Jolly SS, Cairns JA, Yusuf S, TOTAL Investigators et al (2015) Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med 372:1389\u20131398","journal-title":"N Engl J Med"},{"key":"2811_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(15)00448-1","volume":"387","author":"SS Jolly","year":"2016","unstructured":"Jolly SS, Cairns JA, Yusuf S, TOTAL Investigators et al (2016) Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet 387:127\u2013135","journal-title":"Lancet"},{"key":"2811_CR28","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.jcin.2016.06.011","volume":"9","author":"AN Mahmoud","year":"2016","unstructured":"Mahmoud AN, Bavry AA, Elgendy IY (2016) The risk for stroke with aspiration thrombectomy: procedure or patient related? Insights from a meta-analysis. JACC Cardiovasc Interv 9:1750\u20131752","journal-title":"JACC Cardiovasc Interv"},{"key":"2811_CR29","first-page":"65","volume":"18","author":"J Klaudel","year":"2022","unstructured":"Klaudel J, Surman D, Paw\u0142owski K, Trenkner W (2022) Stroke thrombectomy catheter for aspiration of refractory or inaccessible clot in acute myocardial infarction. Postepy Kardiol Interwencyjnej 18:65\u201369","journal-title":"Postepy Kardiol Interwencyjnej"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02811-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02811-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02811-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T08:10:21Z","timestamp":1687335021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02811-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2811"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02811-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"9 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no financial relationships or conflicts of interest regarding the content herein.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}